Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 3 (2006), Issue 11 (November)

1. Lung cancer risk among German male uranium miners: a cohort study, 1946-1998.
   Br J Cancer, 95(9): 1280-7. [Abstract] [Full-text]
2. Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer.
   Br J Cancer, 95(9): 1142-4. [Abstract] [Full-text]
3. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis.
   FASEB J, 20(13): 2384-6. [Abstract] [Full-text]
4. Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives.
   Br J Cancer, 95(9): 1288-90. [Abstract] [Full-text]
5. Severe pulmonary metastasis in obese and diabetic mice.
   Int J Cancer, 119(12): 2760-7. [Abstract] [Full-text]
6. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis.
   Cancer Res, 66(21): 10339-48. [Abstract] [Full-text]
7. Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma.
   Cancer Sci, 97(12): 1388-95. [Abstract] [Full-text]
8. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
   Lancet Oncol, 7(11): 903-9. [Abstract] [Full-text]
9. Targeted therapy in advanced non-small cell lung cancer (NSCLC): where do we stand?
   Cancer Treat Rev, 32(8): 630-6. [Abstract] [Full-text]
10. Clinical review - small cell carcinoma of the bladder.
    Cancer Treat Rev, 32(8): 588-93. [Abstract] [Full-text]
11. Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
    Cancer Treat Rev, 32(8): 583-7. [Abstract] [Full-text]
12. Lung cancer risk prediction: a tool for early detection.
    Int J Cancer, 120(1): 1-6. [Abstract] [Full-text]
13. Exploring the joint effects of silicosis and smoking on lung cancer risks.
    Int J Cancer, 120(1): 133-9. [Abstract] [Full-text]
14. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
    Int J Cancer, 120(1): 24-31. [Abstract] [Full-text]
15. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
    J Cell Physiol, 210(1): 72-80. [Abstract] [Full-text]
16. Relationship between cancer cell proliferation, tumour angiogenesis and 201Tl uptake in non-small cell lung cancer.
    Nucl Med Commun, 27(12): 989-97. [Abstract] [Full-text]
17. CT-guided thoracic core biopsies: value of a negative result.
    Cancer Imaging, 6: 163-7. [Abstract] [Full-text]
18. A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma.
    Vaccine, 24(47): 6994-7002. [Abstract] [Full-text]
19. Type 1 pleuropulmonary blastoma in a 3-year-old male with a cystic lung mass.
    J Pediatr Surg, 41(11): e13-5. [Abstract] [Full-text]
20. DNA repair and cell cycle control genes and the risk of young-onset lung cancer.
    Cancer Res, 66(22): 11062-9. [Abstract] [Full-text]
21. Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.
    Cancer Res, 66(22): 10911-8. [Abstract] [Full-text]
22. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.
    Cancer Res, 66(22): 10677-82. [Abstract] [Full-text]
23. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.
    J Neurol Neurosurg Psychiatry, 77(12): 1359-62. [Abstract] [Full-text]
24. Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
    J Clin Oncol, 24(33): 5253-8. [Abstract] [Full-text]
25. Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.
    J Clin Oncol, 24(33): 5247-52. [Abstract] [Full-text]
26. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    J Clin Oncol, 24(33): 5242-6. [Abstract] [Full-text]
27. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    J Intern Med, 260(6): 545-50. [Abstract] [Full-text]
28. A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
    Cancer Chemother Pharmacol, 59(1): 51-9. [Abstract] [Full-text]
29. Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
    Cancer Chemother Pharmacol, 59(1): 1-7. [Abstract] [Full-text]
30. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Am J Surg Pathol, 30(12): 1546-53. [Abstract] [Full-text]
31. Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells.
    Cancer Immunol Immunother, 56(1): 25-34. [Abstract] [Full-text]
32. Anomalous right upper lobe venous drainage.
    Ann Thorac Surg, 82(6): 2272-4. [Abstract] [Full-text]
33. Thymic small cell carcinoma associated with pulmonary squamous cell carcinoma.
    Ann Thorac Surg, 82(6): 2266-8. [Abstract] [Full-text]
34. Antegrade versus retrograde isolated lung perfusion: doxorubicin uptake and distribution in a sarcoma model.
    Ann Thorac Surg, 82(6): 2024-30. [Abstract] [Full-text]
35. Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature.
    Ann Thorac Surg, 82(6): 2010-3. [Abstract] [Full-text]
36. Retrospective analysis of the clinical performance of anterior mediastinotomy.
    Ann Thorac Surg, 82(6): 2004-9. [Abstract] [Full-text]
37. Technical innovations of carinal resection for nonsmall-cell lung cancer.
    Ann Thorac Surg, 82(6): 1989-97; discussion 1997. [Abstract] [Full-text]
38. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients.
    Ann Thorac Surg, 82(6): 1982-7; discussion 1987-8. [Abstract] [Full-text]
39. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
    Cancer, 107(11): 2637-46. [Abstract] [Full-text]
40. Radiosurgery for the treatment of spinal lung metastases.
    Cancer, 107(11): 2653-61. [Abstract] [Full-text]
41. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
    J Clin Oncol, 24(34): 5448-53. [Abstract] [Full-text]
42. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.
    J Clin Oncol, 24(34): 5441-7. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.